Oncolytics Biotech Inc.ONCYNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank71
3Y CAGR+1.8%
5Y CAGR-9.8%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+1.8%/yr
vs -3.0%/yr prior
5Y CAGR
-9.8%/yr
Recent acceleration
Acceleration
+4.8pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 14.79% |
| 2023 | 36.25% |
| 2022 | -16.89% |
| 2021 | 14.03% |
| 2020 | 1.78% |
| 2019 | 24.83% |
| 2018 | 13.99% |
| 2017 | 15.86% |
| 2016 | 4.42% |
| 2015 | 2.74% |